why choose us

First received: May 15, 2023

Clinical Trial: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Advanced Solid Tumor

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Brief Summary: The purpose of this dose escalation study is to evaluate the safety profile of escalating doses and dose schedules of NXP900.

Read more